The Embryo Project Encyclopedia (https://embryo.asu.edu) is an open-access digital encyclopedia devoted to recording and contextualizing the science of embryos, development, and reproduction. The collection of documents, images, and multimedia housed here serves as the Encyclopedia's permanent archive.

Jane Maienschein, ASU University Professor, Regents Professor, and Director of the Biology and Society Program, started the Embryo Project Encyclopedia in 2007 with support from the National Science Foundation.

Displaying 1 - 1 of 1
Filtering by

Clear all filters

173642-Thumbnail Image.png
Description

Leuprolide acetate, or leuprorelin, is a manufactured drug that has been prescribed as a treatment for endometriosis, a medical condition in which body tissue that typically lines the uterus grows outside of the uterus, since 1989. Leuprorelin is a modified version of a gonadotropin-releasing hormone, a type of hormone that

Leuprolide acetate, or leuprorelin, is a manufactured drug that has been prescribed as a treatment for endometriosis, a medical condition in which body tissue that typically lines the uterus grows outside of the uterus, since 1989. Leuprorelin is a modified version of a gonadotropin-releasing hormone, a type of hormone that helps regulate the female menstrual cycle. The drug inhibits the production of estrogen, a female sex hormone that enables endometrial gland growth. After two weeks of injections, leuprorelin stops the production of estrogen, and without estrogen, endometrial glands become inactive. That decreases the growth of uterine tissue outside of the uterus, which helps decrease the pain associated with endometriosis. Although physicians commonly prescribe leuprorelin as of 2019, women with endometriosis have reported adverse side effects and health complications.

Created2019-11-30